Prediction of ROR1 and CAV1 expression from whole-exome sequencing of tumor tissue and plasma cfDNA to infer the efficacy of B013 plus nab-paclitaxel in triple-negative breast cancer
Min Jiang, Dongming Zhang, Yi-Ching Hsueh, Yu Zhao, Shuhua Zhao, 张强祖, Min Huang, Panjun Gao, Xiaohong Liu, Yuhan Liu, Qihuang Jin, Wenbin Dong, Jing Zhang, Ran Ran, Ruyan Zhang, , Gang Niu
The paper predicts ROR1 and CAV1 expression from whole-exome sequencing data to assess response to B013 plus nab-paclitaxel in triple-negative breast cancer, showing agreement with observed responses in 9 out of 10 patients.
medRxiv · Oct 5, 2026 · PreprintGenetic & Genomic Medicine